BioNTech SE (BNTX)

87.71 -2.49 (-2.76%) USD  |  NASDAQ  |  Oct 16, 16:00
87.78 +0.07 (+0.08%) After-Hours: 20:00
More

BioNTech Cash from Investing (Quarterly) : -118.82M for June 30, 2026

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -118.82M
March 31, 2026 3.101B
December 31, 2025 -3.086B
September 30, 2025 -994.84M
June 30, 2025 -27.66M
March 31, 2025 1.312B
December 31, 2024 649.24M
September 30, 2024 -162.62M
June 30, 2024 -248.84M
March 31, 2024 -2.501B
December 31, 2023 -2.835B
September 30, 2023 -1.353B
June 30, 2023 -2.491B
Date Value
March 31, 2023 -789.04M
December 31, 2022 -170.64M
September 30, 2022 -95.10M
June 30, 2022 -93.49M
March 31, 2022 322.41M
December 31, 2021 -551.06M
September 30, 2021 -48.80M
June 30, 2021 -35.88M
March 31, 2021 -34.09M
December 31, 2020 -115.54M
September 30, 2020 -23.24M
June 30, 2020 -10.61M
March 31, 2020 -16.45M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Moderna, Inc. 329.00M
Mereo BioPharma Group Plc -0.0004M
NuCana Plc -0.0453M
Immatics NV -9.277M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly) 12.56M
Cash from Financing (Quarterly) -126.88M
Free Cash Flow 424.34M
Free Cash Flow Per Share (Quarterly) -0.2077
Free Cash Flow to Equity (Quarterly) -64.68M
Free Cash Flow to Firm (Quarterly) -48.28M
Free Cash Flow Yield 1.96%